Report Categories
View AllRecent Articles
View All
Jakk Stock Analysis Jakks Pacific Inc. Toy Stock Sits At 20.17 With Mild Daily Gain 20260403 1
Plab Stock Analysis Photronics Inc Semiconductor Stock Posts 4.75 Daily Gain To Hit 42.33 Level 20260401
CWAN Clearwater reports narrow Q4 2025 EPS miss shares tick slightly lower on muted investor sentiment
TBMC Trailblazer highlights robust crossindustry merger pipeline as core priority in new quarterly earnings report
Illumina Inc ILMN DRAGEN v45 Genomic Software Upgrade Reinforces Precision Medicine Positioning Amid Mixed Fundamental Outlook
What Wall Street expects from Perdoceo PRDO this quarter Perdoceo posts 71 EPS beat vs analyst estimates
Why Arcosa ACA is a smarter play than most realize 255 20260508
iShares MSCI Germany ETF EWG Poised for Thematic Upside Amid Iran CeasefireDriven Energy Normalization
How Dollar Gen DG balances growth with profitability Bullish Momentum 20260505
What OI Glass OIs 519 Decline Means for Investors 20260515
Q2 Holdings QTWO Stock Up 376 Key Resistance at 4920 20260518
China to Order 200 Boeing Jets Trump Reveals in Fox News Interview
Pyxis Tankers PXS Surges 346 Nearing 471 Resistance 20260519
Gain Therapeutics GANX Stock Slides 385 Support at 166 20260517
Blackrock MHD Stock Today Drops 121 Key Support at 1092 20260517
Genpact Limited G Stock Analysis Climbs 142 Eyes on 3373 20260520
Gyrodyne LLC GYRO Stock Analysis RangeBound Near 764 20260520
Consumer Prices Rise 38 Annually in April Marking Highest Inflation Since Early 2023
Over 52 Million in Public Funds for Social Housing at Risk as Heylo Companies Enter Administration
Midland MSBIP Holds 2539 Direction Awaited 20260520
WesBanco WSBC Delivers Q1 2026 Beat EPS 091 vs 088 Expected
HFBL Q3 2025 Earnings EPS of 024 Amid a Challenging Rate Environment
European Stocks Open Higher as Markets Eye Potential Progress in Iran Nuclear Talks
MIDD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies
Clorox Q1 2026 Earnings Solid Beat on EPS Amid Quiet Market Response
Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances